Tugarinov V, Torricella F, Ying J, Clore G
J Biomol NMR. 2024; 78(4):199-213.
PMID: 39083133
PMC: 11614955.
DOI: 10.1007/s10858-024-00445-8.
Yoon J, Zhang Y, Her C, Grant R, Ponomarenko A, Ackermann B
Sci Adv. 2024; 10(16):eadl6144.
PMID: 38640233
PMC: 11029814.
DOI: 10.1126/sciadv.adl6144.
Robertson A, Ying J, Bax A
Magn Reson (Gott). 2023; 2(1):129-138.
PMID: 37904772
PMC: 10539749.
DOI: 10.5194/mr-2-129-2021.
Alboreggia G, Udompholkul P, Baggio C, Pellecchia M
J Med Chem. 2023; 66(14):10108-10118.
PMID: 37464766
PMC: 10388297.
DOI: 10.1021/acs.jmedchem.3c01073.
Ayaz P, Lyczek A, Paung Y, Mingione V, Iacob R, de Waal P
Nat Commun. 2023; 14(1):1885.
PMID: 37019905
PMC: 10076256.
DOI: 10.1038/s41467-023-36956-5.
NMR Observation of Sulfhydryl Signals in SARS-CoV-2 Main Protease Aids Structural Studies.
Robertson A, Ying J, Bax A
Chembiochem. 2022; 23(19):e202200471.
PMID: 35972230
PMC: 9537880.
DOI: 10.1002/cbic.202200471.
Validation of an Allosteric Binding Site of Src Kinase Identified by Unbiased Ligand Binding Simulations.
Mingione V, Foda Z, Paung Y, Philipose H, Rangwala A, Shan Y
J Mol Biol. 2022; 434(17):167628.
PMID: 35595169
PMC: 9713948.
DOI: 10.1016/j.jmb.2022.167628.
HIV-1 VIF and human APOBEC3G interaction directly observed through molecular specific labeling using a new dual promotor vector.
Myint W, Schiffer C, Matsuo H
J Magn Reson. 2022; 339:107230.
PMID: 35550909
PMC: 9149140.
DOI: 10.1016/j.jmr.2022.107230.
Molecular Basis of Ca(II)-Induced Tetramerization and Transition-Metal Sequestration in Human Calprotectin.
Silvers R, Stephan J, Griffin R, Nolan E
J Am Chem Soc. 2021; 143(43):18073-18090.
PMID: 34699194
PMC: 8643164.
DOI: 10.1021/jacs.1c06402.
Unambiguous Tracking of Protein Phosphorylation by Fast High-Resolution FOSY NMR*.
Lesovoy D, Georgoulia P, Diercks T, Matecko-Burmann I, Burmann B, Bocharov E
Angew Chem Int Ed Engl. 2021; 60(44):23540-23544.
PMID: 34143912
PMC: 8596425.
DOI: 10.1002/anie.202102758.
Structure and dynamics of the drug-bound bacterial transporter EmrE in lipid bilayers.
Shcherbakov A, Hisao G, Mandala V, Thomas N, Soltani M, Salter E
Nat Commun. 2021; 12(1):172.
PMID: 33420032
PMC: 7794478.
DOI: 10.1038/s41467-020-20468-7.
Fragment-derived modulators of an industrial β-glucosidase.
Makraki E, Darby J, Carneiro M, Firth J, Heyam A, Ab E
Biochem J. 2020; 477(22):4383-4395.
PMID: 33111951
PMC: 7702302.
DOI: 10.1042/BCJ20200507.
Structural Aspects of the Allergen-Antibody Interaction.
Pomes A, Mueller G, Chruszcz M
Front Immunol. 2020; 11:2067.
PMID: 32983155
PMC: 7492603.
DOI: 10.3389/fimmu.2020.02067.
Development of a Fragment-Based Screening Assay for the Focal Adhesion Targeting Domain Using SPR and NMR.
Alvarado C, Stahl E, Koessel K, Rivera A, Cherry B, Pulavarti S
Molecules. 2019; 24(18).
PMID: 31540099
PMC: 6766811.
DOI: 10.3390/molecules24183352.
Improved sensitivity and resolution of in-cell NMR spectra.
Burz D, Breindel L, Shekhtman A
Methods Enzymol. 2019; 621:305-328.
PMID: 31128785
PMC: 6988085.
DOI: 10.1016/bs.mie.2019.02.029.
Structural characterization of B. subtilis m1A22 tRNA methyltransferase TrmK: insights into tRNA recognition.
Degut C, Roovers M, Barraud P, Brachet F, Feller A, Larue V
Nucleic Acids Res. 2019; 47(9):4736-4750.
PMID: 30931478
PMC: 6511850.
DOI: 10.1093/nar/gkz230.
The Inescapable Effects of Ribosomes on In-Cell NMR Spectroscopy and the Implications for Regulation of Biological Activity.
Burz D, Breindel L, Shekhtman A
Int J Mol Sci. 2019; 20(6).
PMID: 30875837
PMC: 6471074.
DOI: 10.3390/ijms20061297.
Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2.
Padua R, Sun Y, Marko I, Pitsawong W, Stiller J, Otten R
Nat Commun. 2018; 9(1):4507.
PMID: 30375376
PMC: 6207724.
DOI: 10.1038/s41467-018-06814-w.
N transverse relaxation measurements for the characterization of µs-ms dynamics are deteriorated by the deuterium isotope effect on N resulting from solvent exchange.
Kumari P, Frey L, Sobol A, Lakomek N, Riek R
J Biomol NMR. 2018; 72(3-4):125-137.
PMID: 30306288
DOI: 10.1007/s10858-018-0211-4.
NMR backbone assignments of the tyrosine kinase domain of human fibroblast growth factor receptor 3 in apo state and in complex with inhibitor PD173074.
Sanfelice D, Koss H, Bunney T, Thompson G, Farrell B, Katan M
Biomol NMR Assign. 2018; 12(2):231-235.
PMID: 29582384
PMC: 6132846.
DOI: 10.1007/s12104-018-9814-7.